Botanical species · safety record

Osmanthus fragrans

The EFSA Compendium of Botanicals holds 10 constituent measurements for Osmanthus fragrans. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Osmanthus fragrans Lour.

10Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Isoflavones2
  • 2,4-dihydroxyacetophenone1
  • 2-hydroxyacetophenone1
  • Chrysophanol1
  • Coumarins1
  • Lignans1
  • Physcion1
  • Pyridine alkaloids1
  • Umbelliferone1

Plant parts

  • Unspecified5
  • Roots and other underground parts3
  • Fruit unspecified2

Preparations

  • Solvent extraction10

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
2,4-dihydroxyacetophenoneUnspecifiedSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
2-hydroxyacetophenoneUnspecifiedSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
ChrysophanolRoots and other underground partsSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
CoumarinsUnspecifiedSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
IsoflavonesUnspecifiedSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
IsoflavonesFruit unspecifiedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
LignansRoots and other underground partsSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
PhyscionRoots and other underground partsSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
Pyridine alkaloidsUnspecifiedSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
UmbelliferoneFruit unspecifiedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yin, Wei., Song, Zu-rong., Liu, Jin-qi., Zhang, Guo-sheng. Chemical constituents of Osmanthus fragrans .. Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2015, vol. 40, no. 4, p. 679-85.
  2. Yin, Wei., Liu, Jin-Qi., Zhang, Guo-Sheng. Chemical constituents of Osmanthus fragrans fruits .. Zhongguo zhong yao za zhi = zhongguo zhongyao zazhi = china journal of chinese materia medica, 2013, vol. 38, no. 24, p. 4329-34.
  3. Huang, Mian., Liu, Miao., Xu, Hao-ran., Peng, Xiao-jiao., Zhou, Fen-jin., Bai, Xue-mei., Li, Shan-yi., Huang, Jing. Studies on the chemical components of the roots of Osmanthus fragrans 'Rixianggui' (II). Hecheng huaxue, 2013, p. 689-691.
  4. Liu, Miao., Yang, Xiao-yan., Peng, Xiao-jiao., Huang, Mian., Xu, Hao-ran., Xiao, Yun-chuan., Ran, Jian., Huang, Jing. Studies on the chemical components of the roots of Osmanthus fragrans 'Rixianggui'. Hecheng huaxue, 2013, p. 306-308.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue